FUSOGENIX
PIPELINE
ABOUT
NEWS
CONTACT
News & Publications
May 26, 2024
Entos, Aegis Life, Oisin Biotechnologies, OncoSenX BIO 2024 Reception
Published by:
Perrin Beatty
March 19, 2024
Aegis Life Receives Investment to Continue Development of DNA-Encoded Therapeutic Antibodies Against Infectious Diseases Using the Fusogenix PLV Platform
Published by:
Perrin H Beatty
February 8, 2024
Feb 8 SDBJ: Entos Expands San Diego Presence, New Carlsbad Facility Scales Up Pipeline Production
Published by:
Perrin Beatty
January 25, 2024
Entos Launches GMP Clinical Manufacturing Facility in Carlsbad, California
Published by:
Perrin Beatty
November 6, 2023
Nature Biopharma Dealmakers How Entos’ delivery platform is realizing the untapped promise of genetic medicines
Published by:
Perrin Beatty
November 3, 2023
Entos Receives Inaugural forward/slash momentum Award!
Published by:
Perrin Beatty
June 9, 2023
Aegis Life Awarded Grant to Develop DNA-encoded Antibodies Against Infectious Diseases
Published by:
Perrin Beatty
February 27, 2023
Talking Biotech Podcast with Kevin Folta. Reinventing Lipid Nanoparticles - John Lewis
Published by:
Perrin H Beatty
January 5, 2023
Event: Entos in San Francisco for JPM Week 2023
Published by:
November 8, 2022
ASTech 2022 Award for Outstanding Achievement in Health: Entos Pharmaceuticals!
Published by:
Perrin Beatty
September 1, 2020
Press Release: Aegis Life, Inc. Launches to Fight COVID-19 via DNA Vaccines and Therapeutics Enabled by Proprietary Fusogenix Delivery Technology
Published by:
Perrin Beatty
November 1, 2018
Entos Pharmaceuticals joins JLABS San Diego
Published by:
Entos Pharmaceuticals
July 2, 2018
Entos awarded entry into the Merck Invention Accelerator
Published by:
Entos Pharmaceuticals
March 30, 2018
Entos and Oisin Bio Announce Fusogenix License for SENSOlytics™
Published by:
Entos Pharmaceuticals
June 26, 2018
Entos and Oisin Bio Launch OncoSenX: A Spinoff Company Targeting Cancer
Published by:
John D. Lewis, PhD
Entos Pharmaceuticals
33 St James's Square
London, UK, SW1Y 4JS
Unit 4550, 10230 Jasper Avenue
Edmonton, Alberta, Canada
T5J 4P6
3040 Science Park Road, Suite 1100
San Diego, CA 92121
General Contact
Tel: 1-800-727-0884
Email:
info@entospharma.com
Investor Contact
Email:
info@entospharma.com
Media Contact
Email:
media@entospharma.com
Careers Contact
Email:
careers@entospharma.com
Name
Email Address
Company Name
Message
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.